Impact of reduced exposure to calcineurin inhibitors on the development of de novo DSA: a cohort of non-immunized first kidney graft recipients between 2007 and 2014

BACKGROUND: In low-immunological risk kidney transplant recipients (KTRs), reduced exposure to calcineurin inhibitor (CNI) appears particularly attractive for avoiding adverse events, but may increase the risk of developing de novo Donor Specific Antibodies (dnDSA). METHODS: CNI exposure was retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Girerd, S., Schikowski, J., Girerd, N., Duarte, K., Busby, H., Gambier, N., Ladrière, M., Kessler, M., Frimat, L., Aarnink, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139146/
https://www.ncbi.nlm.nih.gov/pubmed/30219043
http://dx.doi.org/10.1186/s12882-018-1014-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139146/
https://www.ncbi.nlm.nih.gov/pubmed/30219043
http://dx.doi.org/10.1186/s12882-018-1014-2

Ejemplares similares